FFOXFundX Future Fund Opportunities ETF
Seeks capital appreciation.
By Fund X · Launched 2025
Annual Cost
1.02%
#5,438 of 6,040 · expensive
Fund Size
$235M
#2,318 of 6,040 · mid-size
Return (1Y)
+4.3%
Track Record
1 year
#4,362 of 6,040 · young
Performance
Total-return NAV · USDGrowth of $10,000
$10,451+4.5%
Total-return NAV, USD. Net of fund fees, before tax.
What's inside
How Beacon categorizes this fundHoldings
By weightConcentration
Top 10 holdings = 26.8% of funddiversified
First American Government Obli
6.0%
TechnipFMC PLC
3.3%
Millicom International Cellula
3.1%
Globus Medical Inc
2.3%
Ionis Pharmaceuticals Inc
2.2%
Guardant Health Inc
2.2%
BWX Technologies Inc
2.0%
Halozyme Therapeutics Inc
2.0%
Advanced Drainage Systems Inc
1.9%
Onto Innovation Inc
1.9%
Asset allocation
Stocks
97.7%
Cash
2.4%
By sector
Industrials
26.6%
Healthcare
22.8%
Technology
21.9%
Consumer Cyclical
11.9%
Financial Services
5.3%
Consumer Defensive
4.7%
Basic Materials
3.0%
Communication
2.2%
Other
1.6%
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsVolatility (1Y)
18.3%Moderate
Year-on-year price swings
Max drawdown
-12.4%Mild
Worst peak-to-trough loss
Sharpe (3Y)
Unavailable
Needs 3+ years of history
Sortino (3Y)
Not yet
Needs 3+ years of history
Listing
- Exchange
- NYSE Arca
Full fund details
- Objective
- Seeks capital appreciation.
- Strategy
- Actively manages a portfolio of U.S. exchange-listed equity securities and ADRs of small to mid-cap companies, focusing on thematic winners positioned to benefit from long-term megatrends. Investments may include common stock, preferred stock, ETFs, and foreign securities in both developed and emerging markets.
- Inception date
- June 9, 2025
- Fund family
- Fund X
Similar funds
Same asset class, closest by strategy & exposureNext steps
Save FFOX to compare it with other funds, or start building a portfolio.
Data updated on 2026-09-18